Potential negative consequences of non‐consented switch of inhaled medications and devices in asthma patients
Open Access
- 16 June 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 67 (9), 904-910
- https://doi.org/10.1111/ijcp.12202
Abstract
BackgroundAsthma requires individually tailored and careful management to control and prevent symptoms and exacerbations. Selection of the most appropriate treatment is dependent on both the choice of drugs and inhaler device; however, financial pressures may result in patients being switched to alternative medications and devices in an attempt to reduce costs.Keywords
This publication has 46 references indexed in Scilit:
- Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatmentAllergy, 2010
- What happens to patients who have their asthma device switched without their consent?Primary Care Respiratory Journal, 2010
- Inhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulmonary Medicine, 2009
- Impact of Fixed-Dose Combination Drugs on Adherence to Prescription MedicationsJournal of General Internal Medicine, 2008
- Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agentsAmerican Journal of Health-System Pharmacy, 2007
- Can asthma control be improved by understanding the patient's perspective?BMC Pulmonary Medicine, 2007
- Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care dataAnnals of Allergy, Asthma & Immunology, 2006
- The way forward: dry powder inhalers should only be switched with physician agreement and patient trainingInternational Journal of Clinical Practice, 2005
- Do all dry powder inhalers show the same pharmaceutical performance?International Journal of Clinical Practice, 2005
- Chapters 1-3Thorax, 2003